| scholarly article | Q13442814 |
| P2093 | author name string | Wittes R | |
| P2860 | cites work | Antimalarials | Q72636802 |
| CHLOROQUINE NEUROMYOPATHY | Q76644755 | ||
| Chloroquine ototoxicity—a reversible phenomenon? | Q28328103 | ||
| Chloroquine induced haemolysis and acute renal failure in subjects with G-6-PD deficiency | Q28328269 | ||
| Motor polyneuroapthy and nystagmus associated with chloroquine phosphate | Q28328646 | ||
| Chloroquine induced involuntary movements | Q28331226 | ||
| Complete heart block due to chronic chloroquine toxicity managed with permanent pacemaker | Q28331954 | ||
| Amodiaquine-induced involuntary movements | Q28334568 | ||
| Neuromyopathy associated with amodiaquine hydrochloride | Q28361908 | ||
| Letter: Neuromyopathy during malaria suppression with chloroquine | Q28364096 | ||
| Chloroquine neuromyopathy associated with keratopathy and retinopathy | Q28365142 | ||
| Uveal pigment and phenothiazine compounds | Q34229936 | ||
| Plasmodium falciparum malaria mimicking autoimmune hemolytic anemia during pregnancy | Q34301304 | ||
| Chloroquine-associated pruritus in a European | Q34766436 | ||
| STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618) | Q35307420 | ||
| CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS. | Q35393192 | ||
| Use and Misuse of 4-Aminoquinoline Antimalarials in Tropical Africa and Re-Examination of Itch Reaction to these Drugs | Q39321434 | ||
| Chloroquine-induced pruritus among patients with malaria | Q39556095 | ||
| Lethality and behavioral side effects of chloroquine | Q40328184 | ||
| Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine | Q41915956 | ||
| Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials | Q41921005 | ||
| Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment | Q41921011 | ||
| Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy | Q41921017 | ||
| Pharmacologic actions of 4-aminoquinoline compounds | Q41921024 | ||
| Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate | Q41921033 | ||
| Use of synthetic antimalarial drugs and other agents for rheumatoid arthritis: Historic and therapeutic perspectives | Q41921039 | ||
| Experimental assessment of the protective activity of diazepam on the acute toxicity of chloroquine | Q41921423 | ||
| Chloroquine-induced pigmentation. Case reports. | Q41922375 | ||
| Malaria in pregnant women. Presentation of 2 cases and review of the literature | Q41923922 | ||
| Chronic chloroquine toxicity and heart block: a report of two cases. | Q41926612 | ||
| The early changes in experimental myopathy induced by chloroquine and chlorphentermine. | Q41927324 | ||
| Ototoxicity of chloroquine phosphate. A case report | Q41929011 | ||
| Nonfatal chloroquine poisoning | Q41929507 | ||
| Malaria associated with pregnancy | Q41933938 | ||
| Chloroquine neuromyopathy, a reversible granulovascuolar myopathy | Q41935719 | ||
| The effects of acute chloroquine poisoning with special reference to the heart | Q41937959 | ||
| Chloroquine psychosis | Q41939497 | ||
| The metabolism of chloroquine in man during and after repeated oral dosage | Q41940848 | ||
| THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE. | Q41943335 | ||
| TOXIC PSYCHOSIS DUE TO QUINARCRINE AND CHLOROQUINE. | Q41943987 | ||
| PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY | Q41944252 | ||
| STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY. | Q41944384 | ||
| PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS. | Q41944408 | ||
| PSORIASIS FOLLOWING ADMINISTRATION OF ANTIMALARIAL DRUGS. | Q41944421 | ||
| Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases | Q41946718 | ||
| Chloroquine neuromyopathy | Q42231709 | ||
| Pigmentary retinopathy associated with low-dose thioridazine treatment | Q43180838 | ||
| Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria | Q47899792 | ||
| Chloroquine prophylaxis and antibody response to immunisation | Q47973300 | ||
| Chloroquine-induced involuntary movements. | Q55450631 | ||
| Mechanism of chloroquine induced involuntary movements | Q67574432 | ||
| Chloroquine myopathy | Q68475227 | ||
| Antimalarials and pneumococcal immunization | Q69598466 | ||
| Photosensitivity caused by chloroquine | Q70364219 | ||
| Amodiaquine ocular changes | Q70422223 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| amodiaquine | Q239569 | ||
| chloroquine | Q422438 | ||
| P304 | page(s) | 2644-2649 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | Canadian Family Physician | Q5029982 |
| P1476 | title | Adverse reactions to chloroquine and amodiaquine as used for malaria prophylaxis: a review of the literature | |
| P478 | volume | 33 |
| Q41954790 | Malaria prophylaxis |
| Q68504845 | Prevention of malaria |
| Q35841781 | Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy |
| Q58747914 | Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization |
Search more.